Besides the plethora of biological processes evoked by prostanoids through the binding to their receptors, PGE2 reportedly interacts with various receptor tyrosine kinase (RTK) in a process termed transactivation [4], exemplified by EGFR activation in several cancer cell types [5–10]. The gene discussed is EGFR; the disease is cancer.